Regeneron Pharmaceuticals

Founded in 1988, Regeneron Pharmaceuticals a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. Regeneron is developing various product candidates for treating patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious and other diseases. The company is headquartered in Tarrytown, New York.